In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans (Q41815954)

12 October 2017

In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans (English)

1 reference

12 October 2017

Scedosporium apiospermum

object named as

Scedosporium apiospermum

1 reference

inferred from title

Scedosporium prolificans

object named as

Scedosporium prolificans

1 reference

inferred from title

author

Ana Alastruey-Izquierdo

2

1 reference

12 October 2017

Manuel Cuenca-Estrella

1

object named as

Manuel Cuenca-Estrella

1 reference

12 October 2017

Laura Alcazar-Fuoli

3

1 reference

12 October 2017

Leticia Bernal-Martinez

4

1 reference

12 October 2017

Alicia Gomez-Lopez

5

1 reference

12 October 2017

Maria J Buitrago

6

1 reference

12 October 2017

Emilia Mellado

7

1 reference

12 October 2017

Juan L Rodriguez-Tudela

8

1 reference

12 October 2017

language of work or name

English

0 references

publication date

14 January 2008

1 reference

Antimicrobial Agents and Chemotherapy

12 October 2017

1 reference

12 October 2017

52

1 reference

12 October 2017

1136-1139

1 reference

12 October 2017

3

1 reference

Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Antifungal susceptibilities of the species of the Pseudallescheria boydii complex

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Analysis of the influence of Tween concentration, inoculum size, assay medium, and reading time on susceptibility testing of Aspergillus spp

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Susceptibility of filamentous fungi to voriconazole tested by two microdilution methods

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by National Committee for Clinical Laboratory Standards methods M27-A and M38-P.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258535

Combination antifungal therapy

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18195067

12 December 2020

inferred from PubMed ID database lookup

Antifungal susceptibility testing inAspergillusspp. according to EUCAST methodology

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18195067

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.01160-07

1 reference

12 October 2017

1 reference

12 October 2017

1 reference